The clinical significance of γ-catenin in acute myeloid leukemia

The clinical significance of γ-catenin in acute myeloid leukemia

Jiadai Xu,1 Wei Wu,1 Wenyi Shen,1 Peng Liu2 1Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 2Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China Abstract: Dysregulation of γ-cateni...

Full description

Bibliographic Details
Main Authors:	Xu J, Wu W, Shen W, Liu P
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-06-01
Series:	OncoTargets and Therapy
Subjects:	γ-catenin Acute Myeloid Leukemia (AML) Decitabine
Online Access:	https://www.dovepress.com/the-clinical-significance-of-gamma-catenin-in-acute-myeloid-leukemia-peer-reviewed-article-OTT

Similar Items

Clinical efficacy of decitabine in combination with standard-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia
by: Dou L, et al.
Published: (2019-06-01)

SMG1 Acts as a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia
by: Yahui Du, et al.
Published: (2014-09-01)

γ-Catenin Overexpression in AML Patients May Promote Tumor Cell Survival via Activation of the Wnt/β-Catenin Axis
by: Qian J, et al.
Published: (2020-02-01)

Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemia
by: Jacques Delaunay, et al.
Published: (2014-01-01)

Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia
by: Briot T, et al.
Published: (2017-11-01)

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients with Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study
by: Liu X, et al.
Published: (2021-09-01)

Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity
by: Charlotte Calvo, et al.
Published: (2021-02-01)

Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells
by: Sonia Abou Najem, et al.
Published: (2019-11-01)

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study
by: Xiaoyang Li, et al.
Published: (2019-08-01)

Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
by: Guangjie Zhao, et al.
Published: (2021-09-01)

Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
by: Francesco Tarantini, et al.
Published: (2021-08-01)

Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
by: Vincent G. Sorrentino, et al.
Published: (2021-07-01)

Therapies for acute myeloid leukemia: vosaroxin
by: Sayar H, et al.
Published: (2017-08-01)

Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
by: Bhuwan Giri, et al.
Published: (2019-05-01)

Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
by: Samantha L. Goldman, et al.
Published: (2019-03-01)

Advances in targeted therapy for acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020-05-01)

Acute Myeloid Leukemia (AML) as a model for cancer therapy
by: Farhad eRavandi
Published: (2012-10-01)

Long-Lasting Remission in De Novo Breast Myeloid Sarcoma Treated with Decitabine and Radiotherapy
by: Carla Minoia, et al.
Published: (2019-07-01)

Effective Dendritic Cell-based Immunotherapeutic Vaccines for Acute Myeloid Leukemia (AML)
by: Maryam Nourizadeh, et al.
Published: (2014-11-01)

Genetic Characterization and Risk Stratification of Acute Myeloid Leukemia
by: Pourrajab F, et al.
Published: (2020-03-01)

USING A TRANSGENIC ZEBRAFISH MODEL TO IDENTIFY DOWNSTREAM THERAPEUTIC TARGETS IN HIGH-RISK, NUP98-HOXA9-INDUCED MYELOID DISEASE
by: Deveau, Adam
Published: (2013)

Indirect comparison of azacitidine and decitabine for the therapy of elderly patients with acute myeloid leukemia: a systematic review and network meta-analysis
by: Bingbing Wen, et al.
Published: (2020-03-01)

Clinical Applications of MicroRNAs in Acute Myeloid Leukemia: A Mini-Review
by: Bhavana Bhatnagar, et al.
Published: (2021-08-01)

Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine
by: Li-juan Tang, et al.
Published: (2019-07-01)

Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance
by: Caixia Han, et al.
Published: (2021-04-01)

Aberrant Phenotype in Iranian Patients with Acute Myeloid Leukemia
by: Mehdi Jahedi, et al.
Published: (2014-03-01)

Genetic Mutations in Acute Myeloid Leukemia
by: OV Blau
Published: (2016-07-01)

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
by: Bogdan Popescu, et al.
Published: (2019-12-01)

The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
by: Shi M, et al.
Published: (2019-09-01)

Efficacy and toxicity of cladribine for the treatment of refractory acute myeloid leukemia: a meta-analysis
by: Zhou A, et al.
Published: (2019-05-01)

Defining and treating older adults with acute myeloid leukemia who are ineligible for intensive therapies
by: Kristen ePettit, et al.
Published: (2015-12-01)

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
by: Claudio Cerchione, et al.
Published: (2021-03-01)

Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy
by: Weisberg E, et al.
Published: (2017-12-01)

Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells
by: Amany Almars, et al.
Published: (2019-06-01)

Extramedullary Acute Myeloid Leukemia (AML): Leukemic Pleural Effusion, Case Report and Review of the Literature
by: Naveen ePemmaraju, et al.
Published: (2014-06-01)

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
by: Matteo Molica, et al.
Published: (2021-02-01)

Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
by: Kathrin Renner, et al.
Published: (2018-11-01)

Factors associated with intensity of end-of-life care for patients with acute myeloid leukemia
by: Vaughn, Dagny
Published: (2020)

High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome
by: Fatere Seyedalipour, et al.
Published: (2017-07-01)

Cytogenetic and Morphological Analysis of De Novo Acute Myeloid Leukemia in Adults: A Single Center Study in Jordan
by: Ayesh M, et al.
Published: (2012-01-01)